You have 3 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tobramycin, Dexamethasone Drug Combination

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immune Thrombocytopenia (ITP) Trial in Germany (Eltrombopag, Dexamethasone)

Recruiting
  • Immune Thrombocytopenia (ITP)
  • Mannheim, Baden-Wuerttemberg, Germany
  • +24 more
Dec 19, 2022

Multiple Myeloma, Lymphoma, Non-Hodgkin's Trial in United States (CFT7455, Dexamethasone Oral)

Recruiting
  • Multiple Myeloma
  • Lymphoma, Non-Hodgkin's
  • Phoenix, Arizona
  • +12 more
Dec 12, 2022

Multiple Myeloma Trial in Worldwide (Carfilzomib, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Scottsdale, Arizona
  • +139 more
Sep 9, 2022

Relapsed or Refractory Multiple Myeloma Trial in Worldwide (CC-92480, Carfilzomib, Dexamethasone)

Recruiting
  • Relapsed or Refractory Multiple Myeloma
  • Mobile, Alabama
  • +130 more
Jan 27, 2023

Multiple Myeloma Trial (Iberdomide, Bortezomib, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Jul 18, 2022

C.Surgical Procedure; Gastrointestinal Trial in Guangzhou (palonosteron, dexamethasone, and fosaprepitant dissolved in 0.9%

Completed
  • C.Surgical Procedure; Gastrointestinal
  • palonosetron, dexamethasone, and fosaprepitant dissolved in 0.9% NaCl
  • palonosetron, dexamethasone, and 0.9% NaCl
  • Guangzhou, Guangdong, China
    The Sixth Affiliated Hospital of Sun Yat-sen University
Dec 26, 2022

Multiple Myeloma Trial in Worldwide (Teclistamab, Daratumumab, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Tucson, Arizona
  • +189 more
Jan 27, 2023

Leukemia Trial in Houston (Alemtuzumab, Etoposide, Dexamethasone)

Active, not recruiting
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 2, 2022

Multiple Myeloma Trial in United States (Isatuximab, Carfilzomib, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Isatuximab
  • +2 more
  • San Francisco, California
  • +3 more
Dec 24, 2022

Multiple Myeloma, Myeloma Multiple, Myeloma Trial in Poitiers (Drug and medical device)

Not yet recruiting
  • Multiple Myeloma
  • +2 more
  • Drug and medical device
  • Poitiers, France
    CHU Poitiers
Jun 1, 2023

Hepatocellular Carcinoma Trial in New Delhi (N Acetylcysteine, Dexamethasone, Placebo)

Not yet recruiting
  • Hepatocellular Carcinoma
  • N Acetylcysteine
  • +2 more
  • New Delhi, Delhi, India
    Institute of Liver & Biliary Sciences
Sep 8, 2023

Multiple Myeloma, Relapse Multiple Myeloma Trial in Chicago (Belantamab mafodotin, Carfilzomib, Pomalidomide)

Not yet recruiting
  • Multiple Myeloma
  • Relapse Multiple Myeloma
  • Belantamab mafodotin
  • +3 more
  • Chicago, Illinois
    University of Chicago Medicine Comprehensive Cancer Center
Mar 23, 2023

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Los Angeles (drug, other, biological)

Active, not recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Aug 5, 2022

Multiple Myeloma Trial in Italy, Switzerland (Nelfinavir, Lenalidomide, Dexamethasone)

Terminated
  • Multiple Myeloma
  • Milano, Italy
  • +10 more
Jul 4, 2022

Leukemia Trial in Houston (Cyclophosphamide, Vincristine, Blinatumomab)

Not yet recruiting
  • Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Dec 23, 2022

Multiple Myeloma Trial in Worldwide (ACY-241, Pomalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Tucson, Arizona
  • +24 more
Dec 15, 2022

Hepatocellular Carcinoma Trial (Aprepitant in combination with granisetron and dexamethasone, Granisetron and dexamethasone)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Aprepitant in combination with granisetron and dexamethasone
  • Granisetron and dexamethasone
  • (no location specified)
Feb 2, 2023

Relapsed or Refractory Multiple Myeloma Trial in Worldwide (Talquetamab, Daratumumab, Pomalidomide)

Not yet recruiting
  • Relapsed or Refractory Multiple Myeloma
  • Tucson, Arizona
  • +191 more
Aug 11, 2022

Acute Lymphoblastic Leukemia Trial in New York (Ruxolitinib, Dasatinib, Dexamethasone)

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 25, 2022

Multiple Myeloma Trial in United States (Daratumumab, Lenalidomide, Bortezomib)

Recruiting
  • Multiple Myeloma
  • Ann Arbor, Michigan
  • +3 more
Jan 19, 2023

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Los Angeles (Bortezomib, Dexamethasone, Pelareorep)

Not yet recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Los Angeles, California
  • +1 more
Aug 19, 2022

Colorectal Cancer, Metastatic Cancer Trial in New Brunswick, New York (FOLFOX regimen, dexamethasone, floxuridine)

Active, not recruiting
  • Colorectal Cancer
  • Metastatic Cancer
  • FOLFOX regimen
  • +7 more
  • New Brunswick, New Jersey
  • +1 more
Jul 1, 2022

Keratitis; Infectious Disease (Manifestation) Trial in Geneva (PACK-CXL, Cefazolin in combination with either tobramycin or

Completed
  • Keratitis; Infectious Disease (Manifestation)
  • PACK-CXL
  • +4 more
  • Geneva, GE, Switzerland
    University of Geneva
Oct 16, 2020

Multiple Myeloma Trial in Worldwide (Ixazomib, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Helsinki, Finland
  • +25 more
Mar 14, 2022

Postoperative Nausea and Vomiting Trial in Cheras (Dexamethasone, granisetron & palonosetron)

Completed
  • Postoperative Nausea and Vomiting
  • Dexamethasone, granisetron & palonosetron
  • Cheras, Kuala Lumpur, Malaysia
    Hospital Canselor Tuanku Muhriz Universiti Kebangsaan Malaysia
Sep 12, 2023